LC
GSK icon

Lindbrook Capital’s GSK GSK Stock Holding History

Lindbrook Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$129K Buy
3,334
+416
+14% +$15.2K 0.01% 568
2024
Q4 		$98.7K Sell
2,918
-181
-6% -$6.52K 0.01% 564
2024
Q3 		$127K Sell
3,099
-491
-14% -$20.1K 0.01% 492
2024
Q2 		$138K Sell
3,590
-32
-0.9% -$1.35K 0.01% 444
2024
Q1 		$155K Buy
3,622
+568
+19% +$23.4K 0.01% 417
2023
Q4 		$113K Buy
3,054
+101
+3% +$3.63K 0.01% 487
2023
Q3 		$107K Buy
2,953
+987
+50% +$35K 0.01% 448
2023
Q2 		$70.1K Sell
1,966
-749
-28% -$26.9K 0.01% 596
2023
Q1 		$96.6K Buy
2,715
+150
+6% +$5.25K 0.01% 488
2022
Q4 		$90.1K Buy
2,565
+436
+20% +$14.5K 0.01% 517
2022
Q3 		$63K Buy
2,129
+468
+28% +$17.7K 0.01% 569
2022
Q2 		$90K Buy
1,661
+857
+107% +$47.3K 0.01% 464
2022
Q1 		$44K Sell
804
-245
-23% -$13.3K 0.01% 716
2021
Q4 		$58K Sell
1,049
-21
-2% -$1.09K 0.01% 668
2021
Q3 		$51K Buy
1,070
+65
+6% +$3.27K 0.01% 433
2021
Q2 		$50K Buy
1,005
+407
+68% +$19.6K 0.01% 480
2021
Q1 		$27K Sell
598
-465
-44% -$21.1K 0.01% 640
2020
Q4 		$49K Buy
1,063
+150
+16% +$6.89K 0.01% 405
2020
Q3 		$43K Sell
913
-560
-38% -$28.1K 0.01% 391
2020
Q2 		$75K Sell
1,473
-579
-28% -$29.7K 0.02% 264
2020
Q1 		$97K Sell
2,052
-1,804
-47% -$96.2K 0.04% 190
2019
Q4 		$226K Sell
3,856
-96
-2% -$5.34K 0.08% 125
2019
Q3 		$211K Buy
3,952
+613
+18% +$31.5K 0.08% 122
2019
Q2 		$167K Buy
3,339
+157
+5% +$7.88K 0.06% 154
2019
Q1 		$166K Buy
3,182
+822
+35% +$41.1K 0.07% 149
2018
Q4 		$112K Buy
+2,360
New +$116K 0.06% 176

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lindbrook Capital's GSK Position: Q1 2025 in Review

Lindbrook Capital increased its GSK (GSK) stake by 14% in Q1 2025, buying an estimated $15.2K and bringing the position to 3,334 shares worth $129K. The position accounts for 0.01% of the portfolio, ranked #568.

Lindbrook Capital first reported a position in GSK in Q4 2018 and has held it in 26 quarters since. The position peaked at $226K in Q4 2019. 858 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

  • Lindbrook Capital held 3,334 shares of GSK worth $129K as of Q1 2025.
  • Lindbrook Capital bought 416 GSK shares in Q1 2025, an estimated $15.2K.
  • GSK made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #568 holding.
  • Lindbrook Capital first reported a position in GSK in Q4 2018 and has held it in 26 quarters since.
  • Lindbrook Capital's GSK position peaked at $226K in Q4 2019.
  • 858 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.